Sort   by:  
 Page size 
UnknownRecruiting young pre-symptomatic children for a clinical trial in type 1 diabetes: Insights from the Fr1da insulin intervention study.
Not available
S-EPMC6126533 | biostudies-literature
UnknownHorizontal transmission maintains host specificity and codiversification of symbionts in a brood parasitic host.
Not available
S-EPMC10654585 | biostudies-literature
GenomicsBCL6 is required for the initiation and maintenance of chronic myeloid leukemia
We identified the BCL6 protooncogene as a critical downstream effector of FoxO3A in self-renewal signaling of CML-initiating cells. BCL6 represses Arf and p53 in CML cells and is required for leukemia stem cell maintenance, colony formation and initiation of leukemia in transplant recipients. Import...
ORGANISM(S): Homo sapiens 
2011-09-15 | E-GEOD-26085 | biostudies-arrayexpress
UnknownAsthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway.
Not available
S-EPMC1508148 | biostudies-literature
UnknownSex- and system-specific analysis of blood-based biomarkers and frailty in older adults-the Activity and Function of the Elderly study.
Not available
S-EPMC12461695 | biostudies-literature
UnknownLongitudinal associations between the COVID-19 pandemic and sleep characteristics in children and parents.
Not available
S-EPMC12507763 | biostudies-literature
UnknownThe sex ratio distortion in the human head louse is conserved over time.
Not available
S-EPMC428572 | biostudies-literature
TranscriptomicsGene expression data of BCR-ABL1 transformed B cell precursors from BCL6 wild-type and BCL6 knockout mice
To elucidate the mechanism of BCL6-mediated pre-B cell survival signaling, we investigated the gene expression pattern in BCR-ABL1-transformed BCL6+/+ and BCL6-/- B cell precursors. Pharmacological inhibition of BCR-ABL1 was performed with the BCR-ABL1 kinase inhibitor STI571 (Imatinib). BCR-ABL1 t...
ORGANISM(S): Mus musculus 
2010-05-27 | E-GEOD-20987 | biostudies-arrayexpress
UnknownDenosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL.
Not available
S-EPMC4196153 | biostudies-literature
UnknownLiquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma.
Not available
S-EPMC5190002 | biostudies-literature
Sort   by:  
 Page size